Company Overview - Shun Teng International Holdings (00932.HK) reported a closing price of HKD 0.033 per share, with a 10.0% increase and a trading volume of 3.328 million shares, totaling HKD 110,300, and a price fluctuation of 23.33% [1] - The company has experienced a cumulative increase of 25% over the past month, but a year-to-date decline of 3.23%, underperforming the Hang Seng Index, which has risen by 20.75% [2] Financial Performance - For the fiscal year ending March 31, 2025, Shun Teng International Holdings achieved total revenue of HKD 189 million, a year-on-year decrease of 12.96% [2] - The company reported a net profit attributable to shareholders of -HKD 33.4461 million, reflecting a significant decline of 6447.29% [2] - The gross profit margin stood at 77.03%, with a debt-to-asset ratio of 53.15% [2] Valuation and Industry Comparison - Currently, there are no institutional investment ratings for Shun Teng International Holdings [3] - The average price-to-earnings (P/E) ratio for the pharmaceutical and biotechnology industry is 3.78 times, with a median of 6.52 times [3] - Shun Teng International Holdings has a P/E ratio of -2.57 times, ranking 143rd in the industry [3] - Comparatively, other companies in the sector have the following P/E ratios: - Jingyou Pharmaceutical (00858.HK): 0.85 times - Kingsray Biotechnology (01548.HK): 1.44 times - Dongrui Pharmaceutical (02348.HK): 3.05 times - Jilin Changlong Pharmaceutical (08049.HK): 5.86 times - Dajiankang International (02211.HK): 5.97 times [3] Corporate Background - Shun Teng International Holdings Limited is a publicly listed company in Hong Kong (stock code: 932), previously known as Yuyatang Group Holdings Limited, and has been listed on the Hong Kong Stock Exchange since October 11, 2013 [3] - The company primarily engages in the sales, marketing, and distribution of health and beauty supplements and products in Hong Kong and China [3]
顺腾国际控股（00932.HK）7月3日收盘上涨10.0%，成交11.03万港元